IX Common Stock

ORIX Corporation American Depositary Shares · Common Stock

IX logo

IX Common Stock

Latest reported¥221.11B JPY
IX Quarterly Common Stock · JPY (¥40.35B → ¥221.11B)
High-resolution chart · PNG

IX common stock history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

ORIX Corporation American Depositary Shares Common Stock — Quarterly (JPY)
Period endingCommon Stock (JPY)
221,111,000,000
222,069,995,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
221,111,000,000
220,961,000,000
220,724,000,000
220,563,000,000
220,524,000,000
220,524,000,000
220,504,000,000
220,469,000,000
220,469,000,000
220,469,000,000
220,469,000,000
220,458,000,000
220,456,000,000
220,056,000,000
220,051,000,000
220,051,000,000
220,051,000,000
219,546,000,000
214,988,000,000
207,576,000,000
199,401,000,000
194,039,000,000
144,086,000,000
144,026,000,000
0
0
0
0
144,005,000,000
143,995,000,000
143,953,000,000
143,946,000,000
143,946,000,000
143,939,000,000
143,899,000,000
143,899,000,000
102,218,000,000
102,216,000,000
102,216,000,000
104,588,323,560
101,954,121,600
101,605,345,960
99,921,763,140
0
101,237,758,380
98,497,787,520
90,946,964,920
89,821,065,910
88,639,486,200
88,629,944,850
82,558,729,230
76,704,868,240
74,094,613,440
73,025,577,660
51,918,737,200
52,382,524,320
52,093,530,040
52,022,521,450
52,010,725,850
52,185,547,440
52,095,808,800
51,082,404,260
52,143,959,050
51,472,378,530
51,701,908,310
42,053,450,560
42,625,102,260
41,860,490,781
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.